Airway Therapeutics Secures $1.9 Million Grant for Zelpultide Alfa Study on Bronchopulmonary Dysplasia #USA #Atlanta #Airway_Therapeutics #Zelpultide_Alfa #Bronchopulmonary_Dysplasia
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialAirway Therapeutics Secures NIH Grant for Key Clinical Study on Zelpultide Alfa to Combat Lung Disease in Preterm Infants #USA #Atlanta #Airway_Therapeutics #Zelpultide_Alfa #Bronchopulmonary_Dysplasia